Skip to content

Role of buttermilk in treatment of ulcerative colitis

Role of buttermilk in induction and maintenance of remission in mild to moderate ulcerative colitis an open label randomized controlled trial - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/05/111458
Enrollment
40
Registered
2026-05-29
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K519- Ulcerative colitis, unspecified

Interventions

Intervention1: Buttermilk Adjunct Therapy: Participants will receive 250 to300ml buttermilk orally once daily for atleast five days per week for 24 weeks in addition to standard medical therapy for mi

Sponsors

GOVIND BALLABH PANT INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION RESEARCH
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with mild to moderate ulcerative colitis Age above 18 years

Exclusion criteria

Exclusion criteria: Self-reported intolerance to milk and milk-based products Patients on oral or IV antibiotics for any reason Pregnancy or lactation

Design outcomes

Primary

MeasureTime frame
Proportion of individuals in clinical remission [Partial Mayo score (PMS) less than or equal to 2]Timepoint: at 12 weeks

Secondary

MeasureTime frame
Proportion of individuals in clinical remission [Partial Mayo score (PMS) less than or equal to 2]Timepoint: at 4 and 24 weeks;Proportion of individual with Ulcerative colitis endoscopic index of severity (UCEIS) less than or equal to 1Timepoint: at 24 weeks;Proportion of individuals with Faecal calprotectin less than 150mcg/gmTimepoint: at 24 weeks;Proportion of individuals in clinical remission based on bowel wall thickness at the start of therapyTimepoint: at 4,12 and 24 weeks

Countries

India

Contacts

Public ContactRohan Sharma

GOVIND BALLABH PANT INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION RESEARCH

drashokdalal83@gmail.com9718599219

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026